The glucagon/insulin ratio may, on the other hand, be affected by insulin resistance (be it hepatic or peripheral), resulting in increased beta cell secretion (that eventually will fall in line with beta cell failure) and may be invalid in the cases exogenous insulin (late stage type 2 diabetes or type 1 diabetes). This evidence concerns the gene INS and type 2 diabetes mellitus.